Edmond DE Rothschild Holding S.A. Raises Stock Holdings in Kenvue Inc. $KVUE

Key Points

• Edmond DE Rothschild Holding S.A. increased its stake in Kenvue Inc. by 4.5%, acquiring an additional 40,000 shares, bringing its total ownership to 930,000 shares valued at approximately $22.3 million.
• Kenvue reported a quarterly earnings per share (EPS) of $0.29, exceeding analysts' expectations, although the company's revenue decreased by 4.0% compared to the previous year.
• The firm declared a quarterly dividend of $0.2075, which signifies an increase from its previous quarterly payout, representing a 4.1% dividend yield.

Edmond DE Rothschild Holding S.A. increased its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 4.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 930,000 shares of the company's stock after buying an additional 40,000 shares during the period. Edmond DE Rothschild Holding S.A.'s holdings in Kenvue were worth $22,301,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the company. Pittenger & Anderson Inc. acquired a new position in shares of Kenvue during the 1st quarter valued at $30,000. TruNorth Capital Management LLC bought a new stake in Kenvue in the first quarter worth about $36,000. Truvestments Capital LLC bought a new stake in Kenvue in the first quarter worth about $37,000. Clal Insurance Enterprises Holdings Ltd boosted its position in Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock worth $39,000 after purchasing an additional 1,287 shares during the period. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its position in Kenvue by 120.6% during the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company's stock worth $41,000 after purchasing an additional 929 shares during the period. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Royal Bank Of Canada cut their price objective on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research note on Friday, August 8th. Barclays reduced their price objective on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, July 15th. Citigroup cut their target price on shares of Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a report on Tuesday, July 15th. Canaccord Genuity Group lowered their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Bank of America lowered their target price on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Tuesday, July 15th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $24.21.

Kenvue Price Performance

KVUE stock traded up $0.43 during trading on Tuesday, hitting $18.86. The company had a trading volume of 21,104,477 shares, compared to its average volume of 18,178,113. Kenvue Inc. has a fifty-two week low of $17.15 and a fifty-two week high of $25.17. The company has a fifty day moving average price of $21.32 and a two-hundred day moving average price of $22.35. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The company has a market cap of $36.18 billion, a P/E ratio of 25.40, a P/E/G ratio of 2.67 and a beta of 0.83.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm's revenue was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.4%. This is a positive change from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue's dividend payout ratio is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.